HCPLive

Jim Hansen on the Future of the Doctor-Patient Relationship

$shareThis$
Jim Hansen, vice president and executive director of Dossia Consortium, discusses his vision of how health 2.0 tools can enhance the doctor-patient relationship. He believes that communication technology can help doctors and patients get the most out of the limited time available during office visits and allow for improved monitoring of patient health between visits. This video was shot at the Health 2.0 Annual Fall Conference in San Francisco.

Most Popular

Recommended Reading

Tenofovir alafenamide, which results in 90% lower circulating plasma tenofovir than standard tenofovir disoproxil fumarate, is associated with similar virologic response rates as the standard regimen, but with an improved safety profile.
Combination treatment with daclatasvir and asunaprevir plus interferon/ribavirin had high success rates in a 24-week clinical trial for treatment of hepatitis C in patients coninfected with HIV.
An interferon/ribavirin-free pill that combines two drugs to treat patients with certain genotypes of hepatitis C who are also infected with HIV was found to be highly effective in a 12-week trial, clearing the hepatitis C virus from almost all the patients involved.
Novel second-generation HIV-1 maturation inhibitor shows favorable antiviral activity and safety profile in HIV-1, subtype B-infected subjects
$vacMongoViewPlus$ $vAR$